Literature DB >> 21677375

Abnormal tau phosphorylation in the thorny excrescences of CA3 hippocampal neurons in patients with Alzheimer's disease.

Lidia Blazquez-Llorca1, Virginia Garcia-Marin, Paula Merino-Serrais, Jesús Ávila, Javier DeFelipe.   

Abstract

A key symptom in the early stages of Alzheimer's disease (AD) is the loss of declarative memory. The anatomical substrate that supports this kind of memory involves the neural circuits of the medial temporal lobe, and in particular, of the hippocampal formation and adjacent cortex. A main feature of AD is the abnormal phosphorylation of the tau protein and the presence of tangles. The sequence of cellular changes related to tau phosphorylation and tangle formation has been studied with an antibody that binds to diffuse phosphotau (AT8). Moreover, another tau antibody (PHF-1) has been used to follow the pathway of neurofibrillary (tau aggregation) degeneration in AD. We have used a variety of quantitative immunocytochemical techniques and confocal microscopy to visualize and characterize neurons labeled with AT8 and PHF-1 antibodies. We present here the rather unexpected discovery that in AD, there is conspicuous abnormal phosphorylation of the tau protein in a selective subset of dendritic spines. We identified these spines as the typical thorny excrescences of hippocampal CA3 neurons in a pre-tangle state. Since thorny excrescences represent a major synaptic target of granule cell axons (mossy fibers), such aberrant phosphorylation may play an essential role in the memory impairment typical of AD patients.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21677375     DOI: 10.3233/JAD-2011-110659

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  26 in total

1.  Immunohistochemical Analysis of Activin Receptor-Like Kinase 1 (ACVRL1/ALK1) Expression in the Rat and Human Hippocampus: Decline in CA3 During Progression of Alzheimer's Disease.

Authors:  Stephanie L Adams; Laurent Benayoun; Kathy Tilton; Tiffany J Mellott; Sudha Seshadri; Jan Krzysztof Blusztajn; Ivana Delalle
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

2.  In vivo characterization of a bigenic fluorescent mouse model of Alzheimer's disease with neurodegeneration.

Authors:  Sarah E Crowe; Graham C R Ellis-Davies
Journal:  J Comp Neurol       Date:  2013-07-01       Impact factor: 3.215

3.  PhIP exposure in rodents produces neuropathology potentially relevant to Alzheimer's disease.

Authors:  Tauqeerunnisa Syeda; Rachel M Foguth; Emily Llewellyn; Jason R Cannon
Journal:  Toxicology       Date:  2020-03-10       Impact factor: 4.221

4.  Neurobiological substrates underlying the effect of genomic risk for depression on the conversion of amnestic mild cognitive impairment.

Authors:  Jiayuan Xu; Qiaojun Li; Wen Qin; Mulin Jun Li; Chuanjun Zhuo; Huaigui Liu; Feng Liu; Junping Wang; Gunter Schumann; Chunshui Yu
Journal:  Brain       Date:  2018-12-01       Impact factor: 13.501

5.  Acetylcholinesterase protein level is preserved in the Alzheimer's brain.

Authors:  María-Letizia Campanari; María-Salud García-Ayllón; Lidia Blazquez-Llorca; Wilson K W Luk; Karl Tsim; Javier Sáez-Valero
Journal:  J Mol Neurosci       Date:  2013-12-07       Impact factor: 3.444

Review 6.  Behind the curtain of tauopathy: a show of multiple players orchestrating tau toxicity.

Authors:  Yunpeng Huang; Zhihao Wu; Bing Zhou
Journal:  Cell Mol Life Sci       Date:  2015-09-24       Impact factor: 9.261

7.  The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system.

Authors:  Hwan-Ching Tai; Alberto Serrano-Pozo; Tadafumi Hashimoto; Matthew P Frosch; Tara L Spires-Jones; Bradley T Hyman
Journal:  Am J Pathol       Date:  2012-08-04       Impact factor: 4.307

8.  Tau Phosphorylation by GSK3 in Different Conditions.

Authors:  Jesús Avila; Gonzalo León-Espinosa; Esther García; Vega García-Escudero; Félix Hernández; Javier Defelipe
Journal:  Int J Alzheimers Dis       Date:  2012-05-17

9.  Effect of Phosphorylated Tau on Cortical Pyramidal Neuron Morphology during Hibernation.

Authors:  Mamen Regalado-Reyes; Ruth Benavides-Piccione; Isabel Fernaud-Espinosa; Javier DeFelipe; Gonzalo León-Espinosa
Journal:  Cereb Cortex Commun       Date:  2020-05-21

10.  The influence of phospho-τ on dendritic spines of cortical pyramidal neurons in patients with Alzheimer's disease.

Authors:  Paula Merino-Serrais; Ruth Benavides-Piccione; Lidia Blazquez-Llorca; Asta Kastanauskaite; Alberto Rábano; Jesús Avila; Javier DeFelipe
Journal:  Brain       Date:  2013-05-28       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.